OPAQUE Raises $24M for Confidential AI

OPAQUE, a company focused on Confidential AI, has raised a $24 million Series B funding round at a $300 million valuation. The company's platform allows enterprises to run AI models on sensitive and encrypted data. This technology is particularly relevant for the healthcare sector, where data privacy is a primary concern for adopting new AI tools.

- OPAQUE originated from UC Berkeley's RISELab, the same research lab that produced Databricks and Apache Spark. The company's co-founders include professors and former students from Berkeley who also created the open-source MC2 project, which allows multiple parties to train machine learning models on their combined data without revealing their individual datasets. - The Series B funding round was led by Walden Catalyst and included participation from strategic investors like Intel Capital and the Advanced Technology Research Council (ATRC), bringing OPAQUE's total funding to $55.5 million. This investment is aimed at expanding the company's operations and advancing the development of its confidential AI platform for enterprise use. - The core of OPAQUE's platform is its ability to create secure "enclaves" where AI models can process encrypted data. This is a key aspect of confidential computing, which protects data "in use" — a critical vulnerability not addressed by typical data protection methods that focus on data "at rest" (in storage) and "in transit" (moving across a network). - For mobile medical imaging, this technology addresses the significant challenge of sharing and analyzing sensitive patient scans across different locations, such as outpatient centers and hospitals, without violating HIPAA and other privacy regulations. It allows for the development of more robust AI diagnostic tools by training them on diverse datasets from multiple sources without centralizing or exposing the raw patient data. - From a strategic perspective for healthcare executives, confidential AI can reduce the administrative and cost burdens associated with data privacy and compliance. By enabling secure analysis of large datasets, it can help identify trends in outpatient imaging, optimize resource allocation, and improve diagnostic accuracy. - The global confidential computing market is projected to grow significantly, with some estimates suggesting it could reach over $590 billion by 2033, with the healthcare and life sciences sector expected to have one of the highest growth rates. This indicates a major industry shift towards adopting privacy-enhancing technologies to handle sensitive data. - OPAQUE’s platform supports popular AI frameworks like Python and Spark, allowing data scientists to work with familiar tools to analyze encrypted data. This is designed to streamline the integration of confidential AI into existing radiology workflows for tasks like automated image analysis and report generation. - Customers and partners of OPAQUE include major players in technology and financial services such as ServiceNow, Anthropic, and Accenture. This demonstrates a growing enterprise demand for solutions that can securely handle sensitive data in AI applications.

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.